Position in GRAL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,565,025
-$1,143,898 QoQ
Shares Held
30,283
-4.3% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026GABELLI FUNDS LLC holds $32,264,397 across 16 Diagnostics & Research names. GRAL ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
31,017 | $8,275,645 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
14,570 | $7,161,592 | |
| 3 | DHR |
Danaher Corp /De/
|
18,981 | $3,598,797 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
2,500 | $3,153,000 | |
| 5 | WAT |
Waters Corp /De/
|
8,214 | $2,446,129 | |
| 6 | FONR |
Fonar Corp
|
90,514 | $1,679,939 | |
| 7 | GRAL |
GRAIL, Inc.
This page
|
30,283 | $1,565,025 | |
| 8 | A |
Agilent Technologies, Inc.
|
7,854 | $895,198 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,565,025 | 30,283 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,708,923 | 31,650 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,038,388 | 34,473 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,783,708 | 34,689 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $799,657 | 31,310 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $558,883 | 31,310 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $531,039 | 38,593 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $415,543 | 27,036 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||